AN2 Therapeutics Stock Forward View - Accumulation Distribution
| ANTX Stock | USD 1.08 0.04 3.57% |
AN2 Stock outlook is based on your current time horizon.
At this time the rsi of AN2 Therapeutics' share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.22) | EPS Estimate Current Year (1.12) | EPS Estimate Next Year (0.91) | Wall Street Target Price 1 |
Using AN2 Therapeutics hype-based prediction, you can estimate the value of AN2 Therapeutics from the perspective of AN2 Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
AN2 Therapeutics after-hype prediction price | USD 1.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of AN2 Therapeutics to cross-verify your projections. AN2 Therapeutics Additional Predictive Modules
Most predictive techniques to examine AN2 price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for AN2 using various technical indicators. When you analyze AN2 charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 3904.9 | 0.0609 |
| Check AN2 Therapeutics Volatility | Backtest AN2 Therapeutics | Information Ratio |
AN2 Therapeutics Trading Date Momentum
| On February 05 2026 AN2 Therapeutics was traded for 1.08 at the closing time. The top price for the day was 1.15 and the lowest listed price was 1.08 . There was no trading activity during the period 0.0. Lack of trading volume on February 5, 2026 did not affect price variability. The overall trading delta against the current closing price is 3.70% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare AN2 Therapeutics to competition |
Other Forecasting Options for AN2 Therapeutics
For every potential investor in AN2, whether a beginner or expert, AN2 Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. AN2 Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in AN2. Basic forecasting techniques help filter out the noise by identifying AN2 Therapeutics' price trends.AN2 Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AN2 Therapeutics stock to make a market-neutral strategy. Peer analysis of AN2 Therapeutics could also be used in its relative valuation, which is a method of valuing AN2 Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
AN2 Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how AN2 Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AN2 Therapeutics shares will generate the highest return on investment. By undertsting and applying AN2 Therapeutics stock market strength indicators, traders can identify AN2 Therapeutics entry and exit signals to maximize returns.
AN2 Therapeutics Risk Indicators
The analysis of AN2 Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in AN2 Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting an2 stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.6 | |||
| Standard Deviation | 4.08 | |||
| Variance | 16.65 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for AN2 Therapeutics
The number of cover stories for AN2 Therapeutics depends on current market conditions and AN2 Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that AN2 Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about AN2 Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
AN2 Therapeutics Short Properties
AN2 Therapeutics' future price predictability will typically decrease when AN2 Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of AN2 Therapeutics often depends not only on the future outlook of the potential AN2 Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AN2 Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 29.8 M | |
| Cash And Short Term Investments | 83.6 M |
Additional Tools for AN2 Stock Analysis
When running AN2 Therapeutics' price analysis, check to measure AN2 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AN2 Therapeutics is operating at the current time. Most of AN2 Therapeutics' value examination focuses on studying past and present price action to predict the probability of AN2 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AN2 Therapeutics' price. Additionally, you may evaluate how the addition of AN2 Therapeutics to your portfolios can decrease your overall portfolio volatility.